Additional Ventures: Single Ventricle Research Fund (competitive LOI)

Aim: improving outcomes for individuals with single ventricle heart disease by addressing the organ-level complications and sequelae that drive morbidity and mortality.
Priority outcomes include preventing or reversing key organ-level complications such as:

• Lymphatic dysfunction
• Liver disease
• Kidney and gut perfusion impairments
• Heart failure, valve dysfunction, and arrhythmia
• Neurodevelopmental challenges

Funding: Up to $600K over 3 years.

https://www.additionalventures.org/funding/single-ventricle-research-fund/